Multiple Sclerosis and Epstein-Barr virus infection

In summary: SARS-CoV-2 infection and treating those already infected," said Gold.This study found that a substantial percentage of people with COVID-19 (a severe form of co-infection with EBV and SARS-CoV-2) are also infected with EBV, and that if a vaccine were available, it would be beneficial for both preventing SARS-CoV-2 infection and treating those already infected.
  • #1
jim mcnamara
Mentor
4,774
3,830
TL;DR Summary
Infection of brain tissue by the Epstein-Barr virus is found to precede the diagnosis of Multiple Sclerosis.
Statnews article:
https://www.statnews.com/2022/01/13/strong-new-evidence-suggests-virus-triggers-multiple-sclerosis/

Evidence from a colossal blood bank at Walter Reed Army Hospital allowed researchers to look over a long time span of samples for a huge number of US service men/women. The blood bank had multiple samples over time for every service man/woman starting when the person entered the military, usually in their late teens. Epstein-Barr infection was found to increase the subsequent rate of MS by a factor of 32. It often precedes the MS diagnosis by several years.

The article discusses changes in brain tissue that can be found in blood samples, and what changes occur with MS and show up in blood samples. They suggest that a vaccine against EBV would greatly reduce the incidence of MS.
 
  • Informative
  • Like
  • Wow
Likes Oldman too, Klystron, Ygggdrasil and 4 others
Biology news on Phys.org
  • #2
Wow, that's good news. Do we have a vaccine yet for EBV?
 
  • #3
berkeman said:
Do we have a vaccine yet for EBV?
Hmm, looks like that is work in progress...?

https://www.frontiersin.org/articles/10.3389/fimmu.2021.677027/full

1642124260195.png
 
  • Like
  • Informative
Likes Astronuc, russ_watters and atyy
  • #4
Here is one answer about why EBV vaccines are not simple.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636506/
Example claim: human testing could involve increased risk of carcinogenesis and other pathologies under several different scenarios that have come to the fore in development.

In other words testing on human subjects has potential to violate all kinds of ethical boundaries. Kill 'em or cure 'em is not a cool approach.
 
  • Informative
  • Like
Likes Oldman too, Ygggdrasil and berkeman
  • #5
jim mcnamara said:
Here is one answer about why EBV vaccines are not simple.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636506/

The review article lists "the need for additional information on the economic and societal burden of infectious mononucleosis to assess the cost-benefit of a prophylactic vaccine" as an important barrier to the development of an EBV vaccine. Hopefully the connection between EBV infection and MS helps to address this barrier.
 
  • Like
Likes Oldman too and jim mcnamara
  • #6
Here's a link to the paper reporting the discovery, published in the journal Science:

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
https://www.science.org/doi/10.1126/science.abj8222

Abstract:
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system of unknown etiology. We tested the hypothesis that MS is caused by Epstein-Barr virus (EBV) in a cohort comprising more than 10 million young adults on active duty in the US military, 955 of whom were diagnosed with MS during their period of service. Risk of MS increased 32-fold after infection with EBV but was not increased after infection with other viruses, including the similarly transmitted cytomegalovirus. Serum levels of neurofilament light chain, a biomarker of neuroaxonal degeneration, increased only after EBV seroconversion. These findings cannot be explained by any known risk factor for MS and suggest EBV as the leading cause of MS.

Here's one of the key figures from the paper, comparing the prevalence of infection with EBV or cytomegalovirus (CMV, a similar virus used as a control) in patients who later developed MS vs not:
1642206400684.png


The data do make a clear case that EBV infection greatly increases the risk of developing MS, but there are also plenty of people who get infected by EBV but do not go on to develop MS (e.g. ~60% of the MS negative group showed signs of EBV infection in their third sample). So, EBV infection seems likely to be necessary but not sufficient for MS. It will be important to discover the factors that differentiate whether an EBV infection leads to MS in some individuals but not in others. (Perhaps this research could also shed light on the similar problem of why SARS-CoV-2 infection leads to long COVID is some individuals but not others).
 
  • Informative
  • Like
Likes Oldman too, Klystron and berkeman
  • #7
Pardon the anecdotes but note that infectious 'mono' caused by EBV ravaged my age cohort circa 1960's.

I remember sleeping at home for weeks with a persistent sore throat, nursed by my older sister who later became an RN based partially on attending me and dozens of school friends. A close friend from across the country claimed they 'lost nearly a year of childhood due to mono'. The outbreak at my school was traced to water fountains where low water pressure often required mouth contact.

The virus seemed to return with symptoms of sleepiness, tiredness and persistent sore throat concomitant with bouts of flu into early adulthood. While measles infection caused more pain and some minor scars, childhood EBV affected our lives and educations for a much longer period. I understand an effective measles vaccine now exists.

The crux of these anecdotes is that a vaccine for EBV has merit notwithstanding the probable connection to developing multiple sclerosis.
 
  • Like
Likes atyy
  • #8
See also:

Sagittarius A-Star said:
I found something interesting about long covid:

Long COVID and severe COVID-19 infections associated with Epstein-Barr virus reactivation
...
"We ran Epstein-Barr virus serological tests on COVID-19 patients at least 90 days after testing positive for SARS-CoV-2 infection, comparing EBV reactivation rates of those with long COVID symptoms to those who never experienced long COVID symptoms," said lead study author Jeffrey E. Gold of World Organization. "We found over 73% of COVID-19 patients who were experiencing long Covid symptoms were also positive for EBV reactivation."
...
"If a direct role for EBV reactivation in long COVID is supported by further studies, this would provide opportunities to improve the rational diagnosis of this condition and to consider the therapeutic value of anti-herpesvirus agents such as ganciclovir."

Source:
https://www.eurekalert.org/news-releases/612727
 
  • Like
Likes Klystron, Ygggdrasil and Oldman too

FAQ: Multiple Sclerosis and Epstein-Barr virus infection

1. What is the connection between Multiple Sclerosis and Epstein-Barr virus infection?

Multiple Sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system, causing inflammation and damage to the myelin sheath that protects nerve fibers. Epstein-Barr virus (EBV) is a common virus that infects most people at some point in their lives and is known to cause infectious mononucleosis (mono). Studies have shown that individuals with MS are more likely to have been exposed to EBV and may have higher levels of EBV antibodies in their blood, suggesting a possible link between the two.

2. Can Epstein-Barr virus infection cause Multiple Sclerosis?

Currently, there is no definitive evidence that EBV directly causes MS. However, research suggests that EBV infection may trigger an abnormal immune response in individuals who are genetically predisposed to developing MS. This means that while EBV may play a role in the development of MS, it is not the sole cause of the disease.

3. Are all individuals with Multiple Sclerosis infected with Epstein-Barr virus?

No, not all individuals with MS have been infected with EBV. In fact, it is estimated that about 90% of the general population has been exposed to EBV, but only about 50% of individuals with MS have evidence of past EBV infection. This suggests that while EBV may be a risk factor for MS, it is not a necessary factor for developing the disease.

4. Can the Epstein-Barr virus vaccine prevent Multiple Sclerosis?

There is currently no vaccine available for EBV. While there have been some studies exploring the potential of an EBV vaccine for preventing MS, the results have been inconclusive. More research is needed to determine if an EBV vaccine could potentially prevent or reduce the risk of developing MS.

5. Is there a treatment for Multiple Sclerosis associated with Epstein-Barr virus infection?

Currently, there is no specific treatment for MS associated with EBV infection. However, there are various disease-modifying therapies that can help manage the symptoms and slow the progression of MS. Additionally, maintaining a healthy lifestyle and managing stress levels may also help reduce the risk of MS relapses in individuals with EBV infection.

Similar threads

Back
Top